Association between plasma homocysteine and myocardial SPECT abnormalities in patients referred for suspected myocardial ischaemia

Cardiovascular Journal of Africa

Volumn 23, Issue 6, 2012, Pages 313-317

  Ankrah, Alfred ^a   Buscombe, John ^a   Sathekge, Mike Machaba ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Coronary artery disease; Myocardial ischaemia; Myocardial SPECT indices; Plasma homocysteine

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; HOMOCYSTEINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PATIENT REFERRAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UP-REGULATION; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 84864406554     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2011-048     Document Type: Article

References (35)

1. Nasir K, Tsai M, Rosen BD, Fernandes V, Bluemake DA, Folsom AR, et al. Elevated homocysteine is associated with reduced regional left ventricular function. Circulation 2007; 115: 180-187.
2. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis from basic science to clinical medicine. Throm Haemost 2005; 94: 907-915. (Pubitemid 41645928)
3. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and and risk for myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877-881.
4. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, et al. Prospective study for homocysteine and risk of ischaemic stroke among patients with pre-existing coronary heart disease. Stroke 2003; 34: 632-636. (Pubitemid 36307383)
5. Zylberstein DE, Bengstsson C, Bjorkelund C, Landass S, Sundh V, Theille D, et al. Serum homocysteine in relation to mortality and morbidity from coronary artery disease: a 24-year follow up of the population study of the women in Gothenburg. Circulation 2004; 109: 601-606. (Pubitemid 38198867)
6. de Bree, Vershuren VM, Blom HJ, Nadeau M, Trijbels FJ, Kromhout D. Coronary artery disease mortality, plasma homocysteine, and B vitamins: a prospective study. Atherosclerosis 2003; 166: 369-377.
7. Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith DG. Homocysteine and coronary heart disease in the Caerpillay cohort: a 10-year follow up. Heart 2001; 85: 153-158. (Pubitemid 32973585)
8. Clarke R, Hasley J, Lewington S, Lonn E, Armitage J, Manson JE, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause specific mortality: Meta-analysis of 8 randomized trials involving 37 585 individuals. Arch Int Med 2010; 170: 1622-1631.
9. Rossi GP, Seccia TM, Pessina AC. Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link? Clin Chem Lab Med 2007; 45: 1645-1651. (Pubitemid 350232978)
10. Sasso FC, Rambaldi PF, Carbonara O, Nasti R, Torella M, Rotondo A, et al. Perspective of nuclear diagnostic imaging in diabetic cardiomyopathy. Nut Met Cardiovasc Dis 2010; 20: 208-216.
11. Knollman D, Knebel I, Koch K-C, Gebhard M, Krohn T, Buell U, Schaeffer WM, et al. Comparison of SSS and SRS calculated from normal databases provided by QPS and 4D-MSPECT manufacturers and identical institutional normal. Eur J Nuc Med Mol Imaging 2008; 35; 311-318.
12. Nexo E, Engbaek F, Ueland PM, Westby C, O'Gorman P, Johnson C, et al. Evaluation of novel assay in clinical chemistry: quantification of plasma total homocysteine. Clin Chem 2000; 46: 1150-1156. (Pubitemid 30643318)
13. Cerquerria MD, Wiessman NJ, Dilsizian V, Jacobs Ak, Kaul S, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
14. Cragar M, Mahamoudian B, Ayetemir K, Kahraman S, Arc M, Kabakc G, et al. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nuc Med Commum 2006; 27: 61-69. (Pubitemid 44391841)
15. Flemming RM, Harrington GM. What is the relationship between myocardial perfusion imaging and coronary artery disease risk factors and markers of inflammation, Angiology 2008; 59: 16-25. (Pubitemid 351253086)
16. Guent-Rodriguez R-M, Juilliere Y, Nippert M, Abdelmouttaleb I. Herbeth B, Aliot E, et al. Left ventricular systolic dysfynction is an independent predictor of homocysteine in angiographically documented patients with and without coronary artery lesions. J Thromb Haemost 2007; 5: 1209-1216. (Pubitemid 46915261)
17. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VD, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death: the vitamin Intervention for stroke prevention (VISP) randomized controlled trial. J Am Med Assoc 2004; 291: 565-575. (Pubitemid 38500310)
18. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Eng J Med 2006; 354: 1567-1577.
19. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Eng J Med 2006; 354: 1578-1588.
20. Rosenberger D, Gargoum R, Tyagi N, Metreveli N, Sen U, Maldonado C, et al. Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice. Nutr Metab Cardivasc Dis 2011; 21: 492-498. DOI:10.1016/jnumcd.2009.11.014.
21. Okuyan E, Uslu A, Caker MA, Sahin I, Onur I, Enhos A, et al. Homocysteine levels in patients with preserved ejection fraction. Cardiology 2010; 117: 21-27.
22. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischaemic heart disease: a basis for optimum utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
23. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nuc Med 1995; 36: 2138-2147.
24. Germano G, Erel J, Lewin H, Kavangagh PB, Bermen DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial single-photn emission computered tomography. J Nuc Med 1997; 30: 1360-1367. (Pubitemid 27501458)
25. Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, et al. Homocysteine as a risk factor for coronary artery disease and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 2004; 177: 375-381. (Pubitemid 39505271)
26. Soinio M, Marniemi J, Lakso M, Lehto S, Ronnemaa T. Elevated plasma homocysteine levels is an independent predictor of coronary artery events in patients with type 2 diabetes mellitus. Ann Intern Med 2004; 140: 94-100.
27. Sutten-Tyrrel K, Bostom A, Sehlub J, Zeigler-Johnson C. High homocysteine levels are independently related to Systolic hypertension in older adults. Circulation 1997; 96: 1745-1749. (Pubitemid 27400728)
28. Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes. Biochem Soc Trans 2007; 35: 1175-1179. (Pubitemid 350206455)
29. Rodrigo T, Wallter P, Araya J, Orellana M, Rivera G. Homocysteine and essential hypertension. J Clin Pharmacol 2003; 43: 1299-1306. (Pubitemid 37433302)
30. Wald DS, Law M, Morris J. Serum homocysteine and the severity of coronary artery disease. Throm Res 2003; 111: 55-57. (Pubitemid 37485927)
31. Barmpouletos D, Starvens G, Ahlberg AW, Katten DM, O'Sullivan DM, Heller GV. Duration and type of therapy for diabetes: Impact on cardiac risk stratification with stress electrocardiographic-gated SPECT perfusion imaging. J Nuc Cardiol 2010; 17: 1041-1049.
32. Lin Y, Pao K, Yang W, Wu V, Chen Y, Lin Y, et al. Waist to hip ratio correlates with homocysteine levels in males with coronary artery disease. Clin Chem Lab Med 2008; 46: 125-130.
33. Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosendurg IH, Selhub J. Determinants of total plasma homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73: 613-623.
34. Karatela Ra, Sainani GS. Plasma homocysteine, obese, overweight and normal weight hypertensives and non hypertensives. Indian Heart J. 2009; 61: 156-159.
35. Ubbink JB, Vermark WJ, Bennet JM, van Staden DA, Bissbort S. The prevalence of homocystenemia and hypercholesterolemia in angiographically defined coronary artery disease. J Mol Med 1991; 69: 527-534.